Non-reassuring growth
SIPHAT reported a significant performance in the 2nd quarter of 2015, with sales growth of 10.5%, thus, increasing the H1 revenues by 6.4% to TND20.8M. The activity was boosted by sales to hospitals, which grew by 11.8% to TND11.1M. Officinal revenues decreased by 6.5% in this H1 despite almost flat sales in Q2 2015 compared to Q2 2014. Exports improved significantly in Q2 (+82.5%) reaching a growth rate of 56.1% since the beginning of the year.
AlphaMena is the MENA stocks leader in independent equity research, covering 142. MENA securities spanning across 19 sectors and 8 countries relaying on a team of 11 analysts. The breadth of coverage allows AlphaMena to formulate a coherent view on markets, sectors and to highlight the best investments in Mena zone using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.